Inside Health Policy, February 16, 2016. FDA’s device center chief Jeff Shuren highlighted the benefit a robust National Device Evaluation System could have in bolstering the agency’s ability to monitor devices in real-time.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
FDA is Failing to Properly Track Drugs
Legalreader, February 8, 2016. Federal investigators from the Government Accountability Office (GAO) came to the conclusion that the FDA is not doing well at one of its main responsibilities.
Read More »Could This Opioid Implant Really End the Opioid Epidemic?
Buzzfeed, February 8, 2016. NCHR’s Dr. Rupp comments on Probuphine, a six-month implant of buprenorphine for addicts who are “stable” in their recovery from prescription painkiller addiction.
Read More »Is ‘Female Viagra’ Feminist?
In These Times, February 3, 2016. It’s been called the first “Viagra for women” and hailed as a health breakthrough. But Addyi (generic name flibanserin) is sparking ire just as it claims to spark desire. Since the FDA approved Addyi in August 2015, feminist debate on these questions has raged.
Read More »Panel Recommends FDA Approve Implant to Treat Opiate Addiction
USA Today, January 12, 2016. An advisory committee recommended Tuesday that the Food and Drug Administration (FDA) approve an implant designed to reduce addicts’ cravings for heroin or prescription painkillers.
Read More »